RF Acquisition Corp II — Cyborg Score 4/10

Strategic Profile

RF Acquisition Corp II intends to focus on businesses in Asia within the deep technology sector, including artificial intelligence, quantum computing, and biotechnology. On October 2, 2025, RF Acquisition Corp II entered into a Business Combination Agreement with NYB Holdings, signaling an active pursuit of merger targets aligned with its strategic mandate.

Cyborg Score Rationale

RF Acquisition Corp II is a pre-revenue SPAC with a clear technology focus in high-growth sectors (AI, quantum, biotech). The company has successfully identified a business combination target (NYB Holdings/Nanyang Biologics, October 2025) and raised $100M in its May 2024 IPO, but execution risk remains high as SPAC vehicles are inherently speculative until a merger closes.

Top Insights

• (May 2024) Completed $100M IPO at $10.00/unit, raising capital for acquisition strategy
• (October 2025) Announced Business Combination Agreement with NYB Holdings (Nanyang Biologics), signaling imminent merger progression
• Focused geographic and sector mandate (Asia; AI, quantum computing, biotechnology) provides clear acquisition filtering criteria
• Pre-merger SPAC structure with minimal operating overhead; value creation contingent on target company quality and integration execution

Named Competitors

• Asian tech-focused SPACs — Alternative blank-check acquisition vehicles targeting Asian technology companies

Recent Developments

• (May 2024) Closed $100 million initial public offering of 10 million units
• (October 2025) Entered into Business Combination Agreement with NYB Holdings
• (June 2026) Trading near $11.00/share on NASDAQ, maintaining NAV-proximate pricing

Open the full interactive RF Acquisition Corp II report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.